Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gaisser
David M. Gaisser, Gainesville, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20080221701 | Osteostimulative settable bone graft putty - A settable osteostimulative bone graft putty composition having a bioactive glass particulate component composed of a long-term and a short-term component; the long-term component having particle sizes greater than 90 micrometers and the short-term component having particle sizes less than 90 micrometers; the long-term component comprising about 60% to 90% of the bioactive glass osteostimulative particulate component dry weight and the short-term component comprising about 40% to 10%; a binder component having a calcium sulfate component and a calcium silicate component; the calcium sulfate component comprising about 35% to 50% of the binder component dry weight and the calcium silicate component comprising about 65% to 50%; the bioactive glass osteostimulative particulate component being about 20% to 60% of the total putty dry weight composition and the binder being about 80% to 40%; the bioactive glass particulate component and the binder component mixable in water to form the putty. | 09-11-2008 |
| 20100249753 | Vented syringe system and method for the containment, mixing and ejection of wetted particulate material - A vented syringe system and method for particulate containment, mixing and delivery, the system having a vented syringe containing particulate material structured to enable entrapped gases to escape during the injection of liquid into the particulate material, such that gas is removed from the vented syringe prior to ejection of the wetted particulate material. | 09-30-2010 |
Gary Gaisser, Kingsley, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20110125524 | CONTEXT-AWARE METHOD AND SYSTEM FOR FACILITATING THE DELIVERY OF HEALTHCARE TO PATIENTS WITHIN A CLINICAL ENVIRONMENT MONITORED BY REAL-TIME LOCATING APPARATUS - A context-aware method and system for facilitating the delivery of healthcare to patients within a clinical environment monitored by real-time locating apparatus including auto-ID patient tags where patients having tags are located within the environment in real time by the apparatus are provided. The system includes a plurality of self-service units where one or more of the units is configured to store a plurality of auto-ID patient tags and where the one or more of the units includes a dispensing mechanism to dispense stored tags. The system further includes a control computer subsystem coupled to the at least one of the units and including at least one user interface. The subsystem still further includes a processor operable to execute software instructions and a memory operable to store software instructions accessible by the processor. The subsystem still further includes a set of software instructions stored in the memory to at least partially perform the steps of: identifying an incoming patient; assigning a stored auto-ID patient tag to the identified patient to obtain a tag assignment; transmitting a signal over a communication channel to an electronic medical record subsystem to link the tag assignment to a medical record of the patient whereby the patient becomes a linked patient; and controlling the dispensing mechanism to dispense a stored tag to the linked patient. | 05-26-2011 |
Sapine Gaisser, Cambridge GB
| Patent application number | Description | Published |
|---|---|---|
| 20090104666 | Hybrid Glycosylated Products and Their Production and Use - The present invention relates to hybrid glycosylated products, and in particular, to natural products such as polyketides and glycopeptides, and to processes for their preparation. The invention is particularly concerned with recombinant cells in which a cloned microbial glycosyltransferase can be conveniently screened for its ability to generate specific glycosylated derivatives when supplied with polyketide, peptide, or polyketide-peptides as substrates. The invention demonstrates that cloned glycosyltransferases when rapidly screened for their ability to attach a range of activated sugars to a range of exogenously supplied or endogenously generated aglycone templates, show a surprising flexibility towards both aglycone and sugar substrates, and that this process allows the production of glycosylated polyketides in good yield. This overcomes the problem not only of supplying novel sugar attachments to individual polyketides, including polyketides altered by genetic engineering, but also of increasing the diversity of polyketide libraries by combinatorial attachment of sugars. | 04-23-2009 |